The biotechnology sector witnesses another strategic maneuver as private equity firms GHO Capital Partners and Ampersand Capital Partners have agreed to acquire Avid Bioservices for $1.1 billion. Avid, an influential contract development and manufacturing organization (CDMO), specializes in
The pharmaceutical industry has long been a battleground for innovation, with companies around the globe constantly striving to outpace each other in developing cutting-edge therapies. Oncology, the branch of medicine that deals with cancer, has emerged as a focal point of this dynamic competition.
ApiJect Systems Corp., a public-benefit medical technology company, has recently secured an initial grant of $425,000 from the Bill & Melinda Gates Foundation. This significant funding aims to support the design and development of low-cost Prefilled ApiJect Injectors to make single-use prefilled
GC Biopharma and Novelty Nobility have announced a promising partnership aimed at developing a novel treatment for geographic atrophy (GA), a severe form of dry age-related macular degeneration (AMD). This condition leads to retinal damage and eventual blindness, making it a significant health
In the pharmaceutical industry, IT organizations face a critical decision when managing unified clinical development platforms: whether to adopt a product-centric BizDevOps model or a centralized Center of Excellence (CoE) model. This choice is pivotal as pharmaceutical companies strive to bring
Jade Biosciences, a burgeoning developer specializing in immune disease drugs, has set its sights on accelerating its market presence through a reverse merger with Aerovate Therapeutics. This strategic consolidation will enable Jade to promptly enter the public market under the Nasdaq ticker
ISO 15189 accreditation provides a solid framework for quality and technical competence, thereby significantly improving laboratory patient care by establishing comprehensive standards that medical laboratories should meet. Navigate BioPharma Services, Inc.’s recent accreditation by the College of
Artificial Intelligence (AI) has the potential to revolutionize drug discovery and development, offering numerous advantages that could transform current practices in the biopharmaceutical industry. By merging Accenture's advanced capabilities in AI scaling with the innovative ITO™ platform
RTI Surgical recently unveiled a $15 million expansion of its Class III medical device facility in Alachua, Florida, marking a significant milestone in its commitment to advancing tissue engineering. This extensive overhaul includes the addition of a 5,000 square-foot clean room, drastically
Quantum dots, the nanoscale semiconductor particles that exhibit quantum mechanical phenomena, have emerged as a revolutionary tool in biotechnology. Due to their unique optical and electronic properties, quantum dots are being integrated into various applications, enhancing the capabilities of
